However, when KMT2A is disrupted or altered by chromosomal translocations [28], it leads to the formation of fusion proteins that drive the development of leukemia by hijacking normal cellular mechanisms and altering gene expression profiles [29]. This evidence concerns the gene KMT2A and leukemia.